VANCOUVER, British Columbia, May 5, 2026 (GLOBE NEWSWIRE) — MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF); (“”company” or “mind bio”), a biotechnology company commercializing AI-driven speech analytics for drug and alcohol intoxication detection, announced that the company has developed a translingual speech model for drug and alcohol intoxication detection.
The language-independent model is an innovative model for non-invasively detecting various neuroactive substances from audio recordings across cultures and languages.
The technology being developed by MindBio could revolutionize intoxication detection in industries where drug and alcohol testing is mandated by regulatory authorities, such as mining, aviation, and construction, and where large-scale mass testing of a variety of drugs and alcohol is challenging, time-consuming, physically invasive, and expensive to manage.
MindBio has developed the world’s first AI model that can detect various neuroactive substances that impair cognition and performance, and is now integrated into the Edge AI touchscreen kiosk. This technology is an innovation that enables scalable detection of drug use in workplace health, safety, and law enforcement.
“The ability to detect neuroactive substances from voice analysis is a game-changer for scalable intoxication detection to enhance health and safety promotion,” said Justin Hanka, CEO of the company.
For more information, please contact us below.
Justin Hanka, CEO
+61 433140886
justin@mindbiotherapeutics.com
www.mindbiotherapeutics.com
About MindBio Therapeutics Corp.
MindBio is a biotechnology company commercializing AI predictive technology for drug and alcohol addiction detection through voice analysis. The AI predictive model uses over 50 million data points to predict alcohol poisoning with amazing accuracy using just human voice. The company is developing an enterprise platform that includes Edge-AI kiosks, which integrate bespoke hardware and software to detect drug and alcohol intoxication using human voice and AI in various enterprise environments such as mining, aviation, construction, and law enforcement.
Cautionary Note Regarding Forward-Looking Statements:
The press release contains “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to, our ability to complete the offering and option grant in accordance with the announced terms and the development of a voice and AI-powered enterprise platform for use in drug and alcohol intoxication detection. Forward-looking statements include “anticipate,” “intend,” “plan,” “budget,” “believe,” “anticipate,” “estimate,” “expect,” “planned,” “predict,” “strategy,” They can be identified by words such as “will”, “likely”, “may”, “will”, “could”, “will”, “should”, “will” and similar references to the future. periods, negative or similar terms, and terms commonly used in the future and conditions. Forward-looking statements are based on assumptions as of the date they are made. However, there can be no assurance that such assumptions will reflect the actual results of such items or factors.
In addition, there are known and unknown risk factors that may cause our actual results of operations and financial condition to differ materially from those expressed in the forward-looking statements. Therefore, you should not rely on these forward-looking statements. Important risk factors that could cause actual results and financial condition to differ materially from those expressed in the forward-looking statements include: the risk that the Company may not be able to raise the gross proceeds from the offering; failure to obtain final regulatory approval; technical challenges in developing or deploying enterprise platforms; general economic, market and business conditions in Canada and Australia; market volatility. There may be unexpected delays in the timeline of transactions or events described in this press release. All forward-looking information is qualified in its entirety by this cautionary statement.
The Company undertakes no obligation to revise or update such forward-looking statements to reflect future results, events or developments or to publicly release any revisions to the forward-looking information contained herein to reflect future results, events or developments, except as required by law.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of the information in this press release.
